Quantifying Renal Allograft Loss following Early Antibody-Mediated Rejection

Unlike antibody-mediated rejection (AMR) with clinical features, it remains unclear whether subclinical AMR should be treated, as its effect on allograft loss is unknown. It is also uncertain if AMR’s effect is homogeneous across donor (deceased/live) and (HLA/ABO) antibody types. We compared 219 pa...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Am J Transplant
Prif Awduron: Orandi, Babak J., Chow, Eric H. K., Hsu, Annie, Gupta, Natasha, Van Arendonk, Kyle J., Garonzik-Wang, Jacqueline M., Montgomery, John R., Wickliffe, Corey, Lonze, Bonnie E., Bagnasco, Serena M., Alachkar, Nada, Kraus, Edward S., Jackson, Annette M., Montgomery, Robert A., Segev, Dorry L.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4304875/
https://ncbi.nlm.nih.gov/pubmed/25611786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.12982
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg